Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5−/− mice
Accumulating evidence points to an important role for the gut microbiome in anti-tumor immunity. Here, we show that altered intestinal microbiota contributes to anti-tumor immunity, limiting tumor expansion. Mice lacking the ubiquitin ligase RNF5 exhibit attenuated activation of the unfolded protein...
Main Authors: | Li, Y, Tinoco, R, Elmén, L, Goding, C |
---|---|
Format: | Journal article |
Published: |
Springer Nature Publishing Group
2019
|
Similar Items
-
The Tumor and Host Immune Signature, and the Gut Microbiota as Predictive Biomarkers for Immune Checkpoint Inhibitor Response in Melanoma Patients
by: Katarzyna Tomela, et al.
Published: (2020-09-01) -
An epitope encoded by uORF of RNF10 elicits a therapeutic anti-tumor immune response
by: Lili Zeng, et al.
Published: (2023-12-01) -
RNF5: inhibiting antiviral immunity and shaping virus life cycle
by: Junyi Ge, et al.
Published: (2024-01-01) -
Maintenance of Xist Imprinting Depends on Chromatin Condensation State and Rnf12 Dosage in Mice.
by: Atsushi Fukuda, et al.
Published: (2016-10-01) -
Inhibition of anti-tumor immunity by melanoma cell-derived Activin-A depends on STING
by: Katarina Pinjusic, et al.
Published: (2024-01-01)